{"id":404355,"date":"2025-06-27T12:00:00","date_gmt":"2025-06-27T10:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/integrin-modulation-for-the-control-of-metastases-in-cisplatin-resistant-bladder-cancer\/"},"modified":"2025-06-30T16:43:10","modified_gmt":"2025-06-30T14:43:10","slug":"integrin-modulation-for-the-control-of-metastases-in-cisplatin-resistant-bladder-cancer","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/integrin-modulation-for-the-control-of-metastases-in-cisplatin-resistant-bladder-cancer\/","title":{"rendered":"Integrin modulation for the control of metastases in cisplatin-resistant bladder cancer"},"content":{"rendered":"\n<p><strong>Urothelial carcinoma of the urinary bladder is a prime example of the clinical conflict between therapeutic progress and biological resistance. While superficial tumors can often be successfully resected or controlled with intravesical therapies, metastatic or muscle-invasive tumors are often fatal. One of the greatest challenges: cellular resistance to platinum-based chemotherapeutic agents &#8211; especially cisplatin, which is still considered the gold standard in systemic therapy.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fintegrin-modulation-for-the-control-of-metastases-in-cisplatin-resistant-bladder-cancer%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Urothelial carcinoma of the urinary bladder is a prime example of the clinical conflict between therapeutic progress and biological resistance. While superficial tumors can often be successfully resected or controlled&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fintegrin-modulation-for-the-control-of-metastases-in-cisplatin-resistant-bladder-cancer%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":404356,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Artesunate in uro-oncology  ","footnotes":""},"category":[11508,11370,11548,11503,11490],"tags":[83870,17589,83869,17595],"powerkit_post_featured":[],"class_list":["post-404355","post","type-post","status-publish","format-standard","has-post-thumbnail","category-education","category-oncology","category-rx-en","category-studies","category-urology","tag-artesunate","tag-bladder-cancer","tag-cisplatin-en","tag-urothelial-carcinoma","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-16 15:50:56","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":404364,"slug":"modulation-de-lintegrine-pour-le-controle-des-metastases-dans-le-cancer-de-la-vessie-resistant-au-cisplatine","post_title":"Modulation de l'int\u00e9grine pour le contr\u00f4le des m\u00e9tastases dans le cancer de la vessie r\u00e9sistant au cisplatine","href":"https:\/\/medizinonline.com\/fr\/modulation-de-lintegrine-pour-le-controle-des-metastases-dans-le-cancer-de-la-vessie-resistant-au-cisplatine\/"},"it_IT":{"locale":"it_IT","id":404358,"slug":"modulazione-dellintegrina-per-il-controllo-delle-metastasi-nel-cancro-della-vescica-resistente-al-cisplatino","post_title":"Modulazione dell'integrina per il controllo delle metastasi nel cancro della vescica resistente al cisplatino","href":"https:\/\/medizinonline.com\/it\/modulazione-dellintegrina-per-il-controllo-delle-metastasi-nel-cancro-della-vescica-resistente-al-cisplatino\/"},"pt_PT":{"locale":"pt_PT","id":404313,"slug":"modulacao-da-integrina-para-o-controlo-de-metastases-no-cancro-da-bexiga-resistente-a-cisplatina","post_title":"Modula\u00e7\u00e3o da integrina para o controlo de met\u00e1stases no cancro da bexiga resistente \u00e0 cisplatina","href":"https:\/\/medizinonline.com\/pt-pt\/modulacao-da-integrina-para-o-controlo-de-metastases-no-cancro-da-bexiga-resistente-a-cisplatina\/"},"es_ES":{"locale":"es_ES","id":404316,"slug":"modulacion-de-las-integrinas-para-el-control-de-las-metastasis-en-el-cancer-de-vejiga-resistente-al-cisplatino","post_title":"Modulaci\u00f3n de las integrinas para el control de las met\u00e1stasis en el c\u00e1ncer de vejiga resistente al cisplatino","href":"https:\/\/medizinonline.com\/es\/modulacion-de-las-integrinas-para-el-control-de-las-metastasis-en-el-cancer-de-vejiga-resistente-al-cisplatino\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/404355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=404355"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/404355\/revisions"}],"predecessor-version":[{"id":404357,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/404355\/revisions\/404357"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/404356"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=404355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=404355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=404355"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=404355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}